The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency

被引:25
作者
Costa, CG
Dorland, L
de Almeida, IT
Jakobs, C
Duran, M
Poll-The, BT
机构
[1] Univ Childrens Hosp Het Wilhelmina Kinderziekenhu, NL-3512 LK Utrecht, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Clin Chem, Metab Unit, Amsterdam, Netherlands
[3] Univ Lisbon, Fac Farm, Ctr Metab & Genet, P-1699 Lisbon, Portugal
关键词
D O I
10.1023/A:1005354624735
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied a 10-year-old patient with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency who was originally (mis)diagnosed as having systemic carnitine deficiency. He was subjected to a fasting test, a long-chain triglyceride (LCT) loading test (1.5g/kg) and an intravenous carnitine clearance test (0.25 mu mol/kg per min). Plasma acylcarnitines were analysed using a quantitative GC-CI-MS method. During fasting, all long-chain acylcarnitines with a chain length of C-14 and higher (especially C-14:1) increased dramatically. Total plasma long-chain acylcarnitine reached a concentration of 28.6 mu mol/L. LCT loading resulted in a moderate increase, mainly of the C-18 esters. The carnitine infusion, which led to a supranormal plasma free carnitine concentration, gave only a slight but generalized rise of long-chain acylcarnitines. Although only one patient could be tested, the results suggest that the accumulation of potentially toxic long-chain acylcarnitines in VLCAD deficiency is provoked by fasting, LCT loading and carnitine supplementation. Therapy should be adjusted accordingly.
引用
收藏
页码:391 / 399
页数:9
相关论文
共 13 条
[1]  
ADAMS RJ, 1979, J BIOL CHEM, V254, P2404
[2]   VERY LONG-CHAIN ACYL-COA DEHYDROGENASE-DEFICIENCY - IDENTIFICATION OF A NEW INBORN ERROR OF MITOCHONDRIAL FATTY-ACID OXIDATION IN FIBROBLASTS [J].
BERTRAND, C ;
LARGILLIERE, C ;
ZABOT, MT ;
MATHIEU, M ;
VIANEYSABAN, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1180 (03) :327-329
[3]   CARNITINE ESTERS IN METABOLIC DISEASE [J].
BOHLES, H ;
EVANGELIOU, A ;
BERVOETS, K ;
ECKERT, I ;
SEWELL, A .
EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (07) :S57-S61
[4]  
Costa CG, 1997, J LIPID RES, V38, P173
[5]   SYSTEMIC CARNITINE DEFICIENCY - BENEFIT OF ORAL CARNITINE SUPPLEMENTS VS PERSISTING BIOCHEMICAL-ABNORMALITIES [J].
DURAN, M ;
DEKLERK, JBC ;
WADMAN, SK ;
SCHOLTE, HR ;
BEEKMAN, RP ;
JENNEKENS, FGI .
EUROPEAN JOURNAL OF PEDIATRICS, 1984, 142 (03) :224-228
[6]   PRIMARY SYSTEMIC CARNITINE DEFICIENCY .2. RENAL HANDLING OF CARNITINE [J].
ENGEL, AG ;
REBOUCHE, CJ ;
WILSON, DM ;
GLASGOW, AM ;
ROMSHE, CA ;
CRUSE, RP .
NEUROLOGY, 1981, 31 (07) :819-825
[7]   VERY LONG-CHAIN ACYL COENZYME-A DEHYDROGENASE-DEFICIENCY PRESENTING WITH EXERCISE-INDUCED MYOGLOBINURIA [J].
OGILVIE, I ;
POURFARZAM, M ;
JACKSON, S ;
STOCKDALE, C ;
BARTLETT, K ;
TURNBULL, DM .
NEUROLOGY, 1994, 44 (03) :467-473
[8]  
PEARSON DJ, 1969, METHOD ENZYMOL, V14, P1758
[9]  
RASHED MS, 1995, CLIN CHEM, V41, P1109
[10]   ACYLCARNITINES IN INTERMEDIARY METABOLISM [J].
SEWELL, AC ;
BOHLES, HJ .
EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (11) :871-877